Search
Now showing items 1-5 of 5
Papers presented at events
Inactivated SARS-CoV-2 for safe use in analytical and non-clinical trials
| Date Issued:
2022 | Copyright:
open access
Papers presented at events
Development of a therapeutic strategy for COVID-19 based on angiotensin-converting enzyme 2 (ACE-2) recombinant proteins
| Date Issued:
2022 | Copyright:
open access
Papers presented at events
Selection of aptamers which binds human ACE-2 (angiotensin converting enzyme) for blocking RBD (receptor-binding domain) of SARS-CoV-2 protein S
| Date Issued:
2022 | Copyright:
open access
Papers presented at events
High CLEC5A expression on monocytes is related with severe COVID-19
| Date Issued:
2022 | Copyright:
open access
Article
Cellular and Molecular Immunology Approaches for the Development of Immunotherapies against the New Coronavirus (SARS-CoV-2): Challenges to Near-Future Breakthroughs
| Date Issued:
2020 | Copyright:
open access